Moderna, Inc. Income Statement

Income Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.11B0.21B0.14B0.06B0.80B18.47B19.26B6.85B3.24B
Cost of Revenue 0.01B2.62B5.42B4.69B1.46B
Gross Profit 0.11B0.21B0.14B0.06B0.80B15.85B13.85B2.15B1.77B
Operating items
Research & Development 0.27B0.41B0.45B0.50B1.37B1.99B3.29B4.84B4.54B
Selling, General & Administrative 0.06B0.06B0.09B0.11B0.19B0.57B1.13B1.55B1.17B
Other Operating Expenses 0.01B2.62B5.42B4.69B1.46B
Operating Expenses 0.33B0.48B0.55B0.61B1.57B5.17B9.84B11.09B7.18B
Operating Income -0.22B-0.27B-0.41B-0.55B-0.76B13.30B9.42B-4.24B-3.94B
EBIT -0.22B-0.27B-0.41B-0.55B-0.76B13.30B9.42B-4.24B-3.94B
Non-operating items
Interest & Investment Income 0.01B0.02B0.03B0.04B0.03B0.02B0.20B0.42B0.42B
Other Non Operating Income -0.00B-0.00B0.00B-0.01B-0.01B-0.03B-0.04B-0.12B-0.09B
Non Operating Income -0.00B-0.00B0.00B-0.01B-0.01B-0.03B-0.04B-0.12B-0.09B
Net income details
EBT -0.22B-0.26B-0.38B-0.52B-0.74B13.29B9.57B-3.94B-3.61B
Tax Provisions 0.00B-0.00B0.00B-0.00B0.00B1.08B1.21B0.77B-0.05B
Profit After Tax -0.22B-0.26B-0.38B-0.51B-0.75B12.20B8.36B-4.71B-3.56B
Income from Continuing Operations -0.22B-0.26B-0.38B-0.51B-0.75B12.20B8.36B-4.71B-3.56B
Consolidated Net Income -0.22B-0.26B-0.38B-0.51B-0.75B12.20B8.36B-4.71B-3.56B
Income towards Parent Company -0.22B-0.26B-0.38B-0.51B-0.75B12.20B8.36B-4.71B-3.56B
Preferred Dividend Payments 0.01B0.01B0.01B
Net Income towards Common Stockholders -0.23B-0.27B-0.40B-0.51B-0.75B12.20B8.36B-4.71B-3.56B
Additional items
EPS (Basic) -0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.00B-0.00B
EPS (Weighted Average and Diluted) -0.00B-0.00B0.00B0.00B-0.00B-0.00B
Shares Outstanding (Weighted Average) 0.32B0.33B0.40B0.41B0.38B0.38B0.38B
Shares Outstanding (Diluted Average) 0.33B0.38B0.43B0.42B0.38B0.38B
EBITDA -0.22B-0.27B-0.41B-0.55B-0.76B13.30B9.42B-4.24B-3.94B
Tax Rate 0.03%0.19%8.15%12.67%1.28%